<SEC-DOCUMENT>0001193125-24-147040.txt : 20240703
<SEC-HEADER>0001193125-24-147040.hdr.sgml : 20240703
<ACCEPTANCE-DATETIME>20240524160857
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-24-147040
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIODESIX INC
		CENTRAL INDEX KEY:			0001439725
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				203986492
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		919 WEST DILLON ROAD
		CITY:			LOUISVILLE
		STATE:			CO
		ZIP:			80027
		BUSINESS PHONE:		303-417-0500

	MAIL ADDRESS:	
		STREET 1:		919 WEST DILLON ROAD
		CITY:			LOUISVILLE
		STATE:			CO
		ZIP:			80027
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:6pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:6pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g827839g57a04.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:9pt; font-size:6pt; font-family:ARIAL">SIDLEY AUSTIN LLP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:9pt; font-size:6pt; font-family:ARIAL">555 CALIFORNIA
STREET</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:9pt; font-size:6pt; font-family:ARIAL">SUITE 2000</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:9pt; font-size:6pt; font-family:ARIAL">SAN FRANCISCO, CA 94104</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:9pt; font-size:6pt; font-family:ARIAL">+1 415 772 1200</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:9pt; font-size:6pt; font-family:ARIAL">+1 415 772 7400 FAX</P>
<P STYLE="font-size:14pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; line-height:9pt; font-size:6pt; font-family:ARIAL">AMERICA &#149; ASIA PACIFIC &#149; EUROPE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">May&nbsp;24, 2024 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>VIA EDGAR </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States Securities and Exchange
Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">100 F Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Jane Park </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">&#8194;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Lauren Nguyen </P></TD></TR></TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Biodesix, Inc. </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&#8194;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&#8194;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Filed April&nbsp;23, 2024 </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&#8194;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>File <FONT STYLE="white-space:nowrap">No.&nbsp;333-278881</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On behalf of our client, Biodesix, Inc. (the &#147;<U>Company</U>&#148;), we hereby submit this letter in response to comments
from the staff (the &#147;<U>Staff</U>&#148;) of the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) contained in its letter dated May&nbsp;17, 2024 (the &#147;<U>Comment Letter</U>&#148;), relating to the above referenced
Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> filed with the Commission (the &#147;<U>Registration Statement</U>&#148;). We are concurrently filing via EDGAR this letter and an amendment to the Registration Statement on
Form <FONT STYLE="white-space:nowrap">S-1</FONT> (&#147;<U>Amendment No.</U><U></U><U>&nbsp;1</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In this letter,
we have recited the comments from the Staff in italicized, bold type and have followed each comment with the Company&#146;s response in ordinary type. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><U>Form <FONT STYLE="white-space:nowrap">S-1</FONT> filed on April</U><U></U><U>&nbsp;23, 2024</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>General </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>We note your disclosure on page 153 that your selling securityholders may sell their securities
through one or more underwritten offerings on a firm commitment or best efforts basis. Please confirm your understanding that the retention by a selling stockholder of an underwriter would constitute a material change to your plan of distribution
requiring a post-effective amendment. Refer to your undertaking provided pursuant to Item 512(a)(1)(iii) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT></I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In response to the Staff&#146;s comment, the Company has revised the Registration Statement to confirm the Company&#146;s
understanding that the retention by a selling stockholder of an underwritten offering </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
on a firm commitment or best efforts basis would constitute a material change to the Company&#146;s plan of distribution requiring a post-effective amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you
have questions with respect to Amendment No.&nbsp;1 or the responses set forth above, please direct the questions to me at (415) <FONT STYLE="white-space:nowrap">772-1256</FONT> or frahmani@sidley.com. </P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Frank Rahmani</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Frank Rahmani</TD></TR>
</TABLE></DIV> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Scott Hutton, Biodesix, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Robin Harper Cowie, Biodesix, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Chris Vazquez, Biodesix, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Samir A. Gandhi, Sidley Austin LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g827839g57a04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g827839g57a04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  @ 'P# 2(  A$! Q$!_\0
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MK$&HM-JC2+$8TCE4J"BL<YD';'!H YG_ ()665O:?L3>"G@@CA>XN+^69HU
M,K_:I5W,>YVJHR>R@=J^MZ\3_8U^!^L_LY_L\^&O .OWMEJ&J:8]RTMQIQ<P
3L)+B21=I=5/ < Y'7->V4 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
